Found 7 matching trials
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13) PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
Multiple Locations
Learn More & Join Trial
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 China with high incidence of esophageal cancer, the number of new cases and...
Show More Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Show More Location
The Second Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM) PHASE2 Short-course radiotherapy combined with immunotherapy may bring revolutiona...
Show More Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 Esophageal cancer is a prevalent digestive tract tumor, with around 400,000...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 In the management of locally advanced esophageal squamous cell carcinoma, t...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study PHASE2 Neoadjuvant immunochemotherapy can effectively increase the postoperative p...
Show More Location
Multiple Locations
Learn More & Join Trial